Insight into the Medicinal Chemistry of the Endocannabinoid Hydrolase Inhibitors

被引:0
作者
Kapanda, C. N. [1 ]
Poupaert, J. H. [1 ]
Lambert, D. M. [1 ]
机构
[1] Catholic Univ Louvain, LDRI, Med Chem Cannabinoid & Endocannabinoid Res Grp, B-1200 Brussels, Belgium
关键词
Endocannabinoid hydrolases; inhibitors; design; chemical structures; inhibition mechanism; structure-activity relationships; ACID AMIDE HYDROLASE; MONOACYLGLYCEROL LIPASE INHIBITORS; CANNABINOID-RECEPTOR LIGANDS; ACTIVITY IN-VIVO; 2-ARACHIDONOYLGLYCEROL HYDROLYSIS; MOLECULAR CHARACTERIZATION; REVERSIBLE INHIBITORS; MONOGLYCERIDE LIPASE; CB1; RECEPTOR; ANANDAMIDE AMIDOHYDROLASE;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Endocannabinoid hydrolases are nowadays increasingly considered as potential therapeutic targets for treating several pathological states. So far, numerous classes of endocannabinoid hydrolase inhibitors have been described. We herein review the medicinal chemistry of these inhibitors with a particular emphasis on the basis of their design, chemical structure, structure-activity relationships, and inhibition mechanisms.
引用
收藏
页码:1824 / 1846
页数:23
相关论文
共 139 条
  • [1] ABOUABDELLAH A, 2005, Patent No. 2005090292
  • [2] ABOUABDELLAH A, 2005, Patent No. 2005090322
  • [3] ABOUABDELLAH A, 2005, Patent No. 2005077898
  • [4] ABOUADELLAH A, 2005, Patent No. 2005090347
  • [5] Enzymatic pathways that regulate endocannabinoid signaling in the nervous system
    Ahn, Kay
    McKinney, Michele K.
    Cravatt, Benjamin F.
    [J]. CHEMICAL REVIEWS, 2008, 108 (05) : 1687 - 1707
  • [6] Novel mechanistic class of fatty acid amide hydrolase inhibitors with remarkable selectivity
    Ahn, Kyunghye
    Johnson, Douglas S.
    Fitzgerald, Laura R.
    Liimatta, Marya
    Arendse, Andrea
    Stevenson, Tracy
    Lund, Eric. T.
    Nugent, Richard A.
    Nomanbhoy, Tyzoon K.
    Alexander, Jessica P.
    Cravatt, Benjamin F.
    [J]. BIOCHEMISTRY, 2007, 46 (45) : 13019 - 13030
  • [7] The putative endocannabinoid transport blocker LY2183240 is a potent inhibitor of FAAH and several other brain serine hydrolases
    Alexander, Jessica P.
    Cravatt, Benjamin F.
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (30) : 9699 - 9704
  • [8] Mechanism of carbamate inactivation of FAAH: Implications for the design of covalent inhibitors and in vivo functional probes for enzymes
    Alexander, JP
    Cravatt, BF
    [J]. CHEMISTRY & BIOLOGY, 2005, 12 (11): : 1179 - 1187
  • [9] Supply and demand for endocannabinoids
    Alger, Bradley E.
    Kim, Jimok
    [J]. TRENDS IN NEUROSCIENCES, 2011, 34 (06) : 304 - 315
  • [10] Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation
    Alhouayek, Mireille
    Lambert, Didier M.
    Delzenne, Nathalie M.
    Cani, Patrice D.
    Muccioli, Giulio G.
    [J]. FASEB JOURNAL, 2011, 25 (08) : 2711 - 2721